- Ticker
- AADI
- Price
- 8.19
- Stock movement up
- +0.06 (0.74%)
- Company name
- Aadi Bioscience Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 199.80M
- Ent value
- 89.98M
- Price/Sales
- 18.18
- Price/Book
- 1.18
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -4.62%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -50.54%
- 3 year return
- -68.46%
- 5 year return
- -60.08%
- 10 year return
- -
Last updated: 2023-06-06
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
May 10, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
May 10, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
AADI does not pay dividends or no data was received
Loading...
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 18.18 |
| Price to Book | 1.18 |
| EV to Sales | 8.19 |
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
May 9, 2023
iO Charts is a Seeking Alpha partner
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q4 2022 Earnings Conference Call March 28, 2023 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations and...
March 28, 2023
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 24.40M |
| EPS (TTM) | -2.94 |
| FCF per share (TTM) | -3.84 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 10.99M |
| Gross profit (TTM) | 10.00M |
| Operating income (TTM) | -63.16M |
| Net income (TTM) | -62.59M |
| EPS (TTM) | -2.94 |
| EPS (1y forward) | -2.53 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 90.96% |
| Operating margin (TTM) | -574.71% |
| Profit margin (TTM) | -569.57% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 134.81M |
| Net receivables | 2.26M |
| Total current assets | 189.86M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 194.10M |
| Accounts payable | 3.92M |
| Short/Current long term debt | 1.72M |
| Total current liabilities | 17.89M |
| Total liabilities | 25.00M |
| Shareholder's equity | 169.11M |
| Net tangible assets | 169.11M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -80.89M |
| Capital expenditures (TTM) | 676.00K |
| Free cash flow (TTM) | -81.57M |
| Dividends paid (TTM) | 3.77M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -37.01% |
| Return on Assets | -32.25% |
| Return on Invested Capital | -36.93% |
| Cash Return on Invested Capital | -48.13% |
Loading...
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 8.13 |
| Daily high | 8.36 |
| Daily low | 8.05 |
| Daily Volume | 83K |
| All-time high | 1485.00 |
| 1y analyst estimate | 42.50 |
| Beta | - |
| EPS (TTM) | -2.94 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 8 Aug 2023 |
Downside potential
Loading...
Downside potential data
| AADI | S&P500 | |
| Current price drop from All-time high | -99.45% | -10.40% |
| Highest price drop | -99.54% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -77.12% | -11.53% |
| Avg time to new high | 75 days | 13 days |
| Max time to new high | 1389 days | 1805 days |
The following slide deck was published by Aadi Bioscience, Inc.
March 28, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 28, 2023
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
199.80M
Marketcap category
Small-cap
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, including tumor agnostic indications targeting specific genomic alterations that activate the mTOR pathway. The company was incorporated in 2007 and is headquartered in Pacific Palisades, California.
Employees
76
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 27, 2023
iO Charts is a Seeking Alpha partner
Aadi Bioscience is a commercial stage company with a potential label expansion ahead. Click here to learn why I rate AADI stock a Buy.
March 7, 2023
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
March 3, 2023
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q3 2022 Earnings Conference Call November 9, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - Senior Vice President of Investor Relations &...
November 9, 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
November 9, 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
November 8, 2022
The following slide deck was published by Aadi Bioscience, Inc.
November 3, 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
October 12, 2022
The following slide deck was published by Aadi Bioscience, Inc.
September 30, 2022
Get the latest news and real-time alerts from Aadi Bioscience, Inc. (AADI) stock at Seeking Alpha.
September 22, 2022
Aadi Bioscience shares lost half their value since reverse merger with Aerpio Pharmaceuticals. Click here to read why AADI stock is a Buy in my view.
September 21, 2022
Aadi Bioscience, Inc. (NASDAQ:NASDAQ:AADI) Q2 2022 Earnings Conference Call August 10, 2022 8:30 AM ETCompany ParticipantsMarcy Graham - SVP of IR and Corporate CommunicationsNeil Desai -...
August 10, 2022
iO Charts is a Seeking Alpha partnerNext page